Patent · US Active

Anti-CD19 antibody formulations

US11352423B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

MORPHOSYS AG · DE

Inventors

Patrick Garidel · Norderstedt, DE
Andreas Langer · Munich, DE
Martin Hessling · Ulm, DE
Daniel Weinfurtner · Planegg, DE
Bodo BROCKS · Gilching, DE

Key dates

Filing date	Jun 27, 2017
Grant date	Jun 7, 2022
Priority date	—
Expiry date	Nov 5, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.